MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agani, F.
Right arrow Articles by Semenza, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agani, F.
Right arrow Articles by Semenza, G. L.

Vol. 54, Issue 5, 749-754, November 1998

ACCELERATED COMMUNICATION
Mersalyl Is a Novel Inducer of Vascular Endothelial Growth Factor Gene Expression and Hypoxia-Inducible Factor 1 Activity

Faton Agani and Gregg L. Semenza

Institute of Genetic Medicine, Departments of Pediatrics and Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-3914

In response to hypoxia, mammalian cells express multiple gene products [including erythropoietin (EPO) and vascular endothelial growth factor (VEGF)] that serve to increase O2 delivery, as well as glucose transporters and glycolytic enzymes (such as enolase 1) that allow metabolic adaptation to decreased O2 availability. Increased transcription of the genes encoding these proteins in hypoxic cells is mediated by hypoxia-inducible factor 1 (HIF-1), a basic helix-loop-helix transcription factor. Expression of HIF-1 and downstream genes can also be induced by exposure of cells to divalent metals (such as CoCl2) or iron chelators [such as desferrioxamine (DFO)]. We report here that the organomercurial compound mersalyl induced expression of VEGF and enolase 1 mRNA, as well as HIF-1 activity, in cultured cells. Expression of reporter genes containing hypoxia response elements from the EPO and VEGF genes was also induced by mersalyl treatment. However, mersalyl inhibited endogenous EPO mRNA expression induced by hypoxia, CoCl2, or DFO. In cells lacking expression of the insulin-like growth factor-1 receptor, mersalyl did not induce HIF-1 activity or VEGF mRNA expression, whereas induction by hypoxia, CoCl2, or DFO was unaffected. The mitogen-activated protein kinase kinase inhibitor PD098059 markedly reduced induction of HIF-1 by mersalyl but not by hypoxia. These results indicate that mersalyl induces expression of HIF-1 and a subset of hypoxia-inducible genes by a mechanism, involving the insulin-like growth factor-1 receptor and mitogen-activated protein kinase activity, that is distinct from mechanisms of induction by hypoxia, CoCl2, or DFO.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
DiabetesHome page
C. Regazzetti, P. Peraldi, T. Gremeaux, R. Najem-Lendom, I. Ben-Sahra, M. Cormont, F. Bost, Y. Le Marchand-Brustel, J.-F. Tanti, and S. Giorgetti-Peraldi
Hypoxia Decreases Insulin Signaling Pathways in Adipocytes
Diabetes, January 1, 2009; 58(1): 95 - 103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, and G. Cairo
Role of HIF-1 and NF-{kappa}B Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals
J. Biol. Chem., July 25, 2008; 283(30): 20674 - 20686.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. De Ponti, R. Carini, E. Alchera, M. P. Nitti, M. Locati, E. Albano, G. Cairo, and L. Tacchini
Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages
J. Leukoc. Biol., August 1, 2007; 82(2): 392 - 402.
[Abstract] [Full Text] [PDF]


Home page
Plant Cell PhysiolHome page
Y. Hanawa, M. Watanabe, Y. Karatsu, H. Fukuzawa, and Y. Shiraiwa
Induction of a High-CO2-Inducible, Periplasmic Protein, H43, and its Application as a High-CO2-Responsive Marker for Study of the High-CO2-Sensing Mechanism in Chlamydomonas reinhardtii
Plant Cell Physiol., February 1, 2007; 48(2): 299 - 309.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Mylonis, G. Chachami, M. Samiotaki, G. Panayotou, E. Paraskeva, A. Kalousi, E. Georgatsou, S. Bonanou, and G. Simos
Identification of MAPK Phosphorylation Sites and Their Role in the Localization and Activity of Hypoxia-inducible Factor-1{alpha}
J. Biol. Chem., November 3, 2006; 281(44): 33095 - 33106.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Wakisaka, S. Kondo, T. Yoshizaki, S. Murono, M. Furukawa, and J. S. Pagano
Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1{alpha}
Mol. Cell. Biol., June 15, 2004; 24(12): 5223 - 5234.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. Powis and L. Kirkpatrick
Hypoxia inducible factor-1{alpha} as a cancer drug target
Mol. Cancer Ther., May 1, 2004; 3(5): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. H. WENGER
Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression
FASEB J, August 1, 2002; 16(10): 1151 - 1162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G. L. Semenza, and E. Van Obberghen
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
J. Biol. Chem., July 26, 2002; 277(31): 27975 - 27981.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Jung, J. Haendeler, J. Hoffmann, A. Reissner, E. Dernbach, A. M. Zeiher, and S. Dimmeler
Hypoxic Induction of the Hypoxia-Inducible Factor Is Mediated via the Adaptor Protein Shc in Endothelial Cells
Circ. Res., July 12, 2002; 91(1): 38 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, and E. Van Obberghen
Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
J. Biol. Chem., November 16, 2001; 276(47): 43836 - 43841.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Jiang, R. Guo, and J. A. Powell-Coffman
The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia
PNAS, June 20, 2001; (2001) 141234698.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Laughner, P. Taghavi, K. Chiles, P. C. Mahon, and G. L. Semenza
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1{alpha} (HIF-1{alpha}) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
Mol. Cell. Biol., June 15, 2001; 21(12): 3995 - 4004.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
A. Rajakumar, K. A. Whitelock, L. A. Weissfeld, A. R. Daftary, N. Markovic, and K. P. Conrad
Selective Overexpression of the Hypoxia-Inducible Transcription Factor, HIF-2{{alpha}}, in Placentas from Women with Preeclampsia
Biol Reprod, February 1, 2001; 64(2): 499 - 506.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
D. A. Elson, H. E. Ryan, J. W. Snow, R. Johnson, and J. M. Arbeit
Coordinate Up-Regulation of Hypoxia Inducible Factor (HIF)-1{{alpha}} and HIF-1 Target Genes during Multi-Stage Epidermal Carcinogenesis and Wound Healing
Cancer Res., November 1, 2000; 60(21): 6189 - 6195.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
G. L. Semenza
HIF-1 and human disease: one highly involved factor
Genes & Dev., August 15, 2000; 14(16): 1983 - 1991.
[Full Text]


Home page
BloodHome page
R. M. Wanner, P. Spielmann, D. M. Stroka, G. Camenisch, I. Camenisch, A. Scheid, D. R. Houck, C. Bauer, M. Gassmann, and R. H. Wenger
Epolones induce erythropoietin expression via hypoxia-inducible factor-1alpha activation
Blood, August 15, 2000; 96(4): 1558 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.-M. Georgescu, J. W. Simons, and G. L. Semenza
Modulation of Hypoxia-inducible Factor 1{{alpha}} Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics
Cancer Res., March 1, 2000; 60(6): 1541 - 1545.
[Abstract] [Full Text]


Home page
J. Exp. Biol.Home page
R. Wenger
Mammalian oxygen sensing, signalling and gene regulation
J. Exp. Biol., January 4, 2000; 203(8): 1253 - 1263.
[Abstract] [PDF]


Home page
Cancer Res.Home page
D. Feldser, F. Agani, N. V. Iyer, B. Pak, G. Ferreira, and G. L. Semenza
Reciprocal Positive Regulation of Hypoxia-inducible Factor 1{{alpha}} and Insulin-like Growth Factor 2
Cancer Res., August 1, 1999; 59(16): 3915 - 3918.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Richard, E. Berra, and J. Pouyssegur
Nonhypoxic Pathway Mediates the Induction of Hypoxia-inducible Factor 1alpha in Vascular Smooth Muscle Cells
J. Biol. Chem., August 25, 2000; 275(35): 26765 - 26771.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Jiang, R. Guo, and J. A. Powell-Coffman
The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia
PNAS, July 3, 2001; 98(14): 7916 - 7921.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics